Given the aforementioned evidence, it was inferred that Cbl might alleviate endothelial dysfunction in DM by promoting NO production and inhibiting human umbilical vein endothelial cell (HUVEC) apoptosis through downregulation of Runx3 via the inactivated JAK2/STAT4 signaling pathway. This evidence concerns the gene STAT4 and diabetes mellitus.